Study clarifies when CT adds value in canine hyperparathyroidism
Bottom line
Version 1
A new multicenter retrospective study in Veterinary Radiology & Ultrasound compared ultrasound and computed tomography findings in 20 dogs with histopathologically confirmed primary hyperparathyroidism and found that ultrasound remained the better first-line imaging test for identifying abnormal parathyroid glands, while CT may still add value when clinicians are planning treatment. The paper adds species-specific imaging detail to a space where CT descriptions in dogs have been limited, and it reinforces the long-standing role of cervical ultrasound in working up canine primary hyperparathyroidism. (lifescience.net)
Why it matters: For veterinary teams managing hypercalcemic dogs, the study supports sticking with ultrasound as the initial imaging modality, especially because it remains the more sensitive and practical tool for localizing most abnormal parathyroid tissue. That said, CT may help in select cases where anatomy is unclear, where accessory or ectopic tissue is a concern, or where procedural planning could affect whether a dog is steered toward surgery or a percutaneous treatment approach. Prior veterinary references and reviews have also noted that ultrasound is usually the preferred first step, while advanced imaging can be useful in more complex cases. (merckvetmanual.com)
What to watch: Watch for follow-up studies that define when CT changes case management, particularly in dogs being considered for parathyroidectomy or image-guided ablation. (pubmed.ncbi.nlm.nih.gov)
Key facts
- Study type
- Multicenter retrospective study
- Journal
- Veterinary Radiology & Ultrasound
- Sample size
- 20 dogs
- Condition
- Histopathologically confirmed primary hyperparathyroidism
- Main finding
- Ultrasound was better than CT as the first-line imaging test for abnormal parathyroid glands
- CT role
- May add value for treatment planning in selected cases
- CT limitation
- Limited by spatial resolution
- Ultrasound finding
- Produced more accurate measurements
A newly published study is giving veterinary clinicians a clearer picture of where CT fits, and where it doesn’t, in canine primary hyperparathyroidism. In a multicenter retrospective analysis of 20 dogs with histopathologically confirmed disease, investigators found that ultrasound remained superior to CT as the first-line imaging modality for abnormal parathyroid glands, though CT may still help inform therapeutic decision-making in selected cases. (lifescience.net)
That conclusion lands in an area of practice where ultrasound has long been the default, but where CT’s role has been less well defined in dogs. Earlier veterinary literature established high-resolution cervical ultrasound as a practical way to localize enlarged parathyroid glands, and broader clinical references still describe ultrasonography as more sensitive than CT, MRI, or scintigraphy for routine evaluation of suspected primary hyperparathyroidism. (onlinelibrary.wiley.com)
The new study’s value is in directly comparing the two modalities in confirmed cases. According to the abstract and related conference material, the investigators evaluated ultrasonographic and CT characteristics of parathyroid glands in 20 dogs and found CT was limited by spatial resolution, while ultrasound produced more accurate measurements. The authors concluded that CT should not replace ultrasound for first-line localization, but may still contribute when the imaging question is tied to treatment planning. (lifescience.net)
That nuance matters because canine primary hyperparathyroidism can require more than simple lesion detection. In dogs, most cases are due to adenoma or hyperplasia, with carcinoma reported less commonly, and treatment options can include surgery as well as ultrasound-guided ablation techniques in selected patients. In those settings, clinicians may want better anatomic context, especially if there is concern about ectopic or accessory tissue, discordant imaging findings, or persistent disease. Recent and older veterinary sources alike suggest CT can be considered in that second-line role, even if it is not the best screening tool. (ivis.org)
Direct outside commentary on this specific paper appears limited so far, but the study aligns with the direction of other recent veterinary work. A 2025 prospective study on CT and surgery in dogs with primary hyperparathyroidism found that some pathologic parathyroid or thyroid tissue removed at surgery had not been identified on CT, reinforcing the idea that CT can miss clinically relevant lesions. That consistency strengthens the take-home message that CT is useful selectively, not universally. (openalex.org)
Why it matters: For veterinary professionals, this study helps refine imaging algorithms rather than overturn them. If a hypercalcemic dog has biochemical findings consistent with primary hyperparathyroidism, cervical ultrasound still looks like the most efficient first diagnostic step for lesion localization. CT may be best reserved for cases where ultrasound is equivocal, where anatomy is complex, or where procedural planning could change the clinical approach. That’s useful not only for radiologists and internists, but also for surgeons counseling pet parents about next steps, expected costs, and the likelihood that additional imaging will actually alter management. (merckvetmanual.com)
The study also fits a broader shift toward more precise case selection for intervention. Because postoperative hypocalcemia and incomplete localization remain practical concerns, better understanding the strengths and limits of each imaging modality can help teams choose the right test at the right time, rather than defaulting to advanced imaging that may not improve detection. (merckvetmanual.com)
What to watch: The next important question is not whether CT can see some abnormal parathyroid glands, but exactly which dogs benefit enough from CT to justify the added anesthesia, cost, and workflow burden. Prospective studies tied to outcomes, including surgical success and ablation planning, will be the most useful next step. (pubmed.ncbi.nlm.nih.gov)